{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:31:44Z","timestamp":1761647504057,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T00:00:00Z","timestamp":1599177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Taibah University Medical Sciences"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jtumed.2020.08.004","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T08:58:41Z","timestamp":1600160321000},"page":"554-556","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Minimising chemotherapy while optimising immune therapy for paediatric nodular lymphocyte-predominant Hodgkin's lymphoma"],"prefix":"10.1016","volume":"15","author":[{"given":"Roiya","family":"Farhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nof S.","family":"Alqarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali H.","family":"Algiraigri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"20","key":"10.1016\/j.jtumed.2020.08.004_bib1","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jtumed.2020.08.004_bib2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ijrobp.2015.02.012","article-title":"Characteristics and outcomes of patients with nodular lymphocyte-predominant Hodgkin lymphoma versus those with classical Hodgkin lymphoma: a population-based analysis","volume":"92","author":"Gerber","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.jtumed.2020.08.004_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/jayao.2015.0038","article-title":"Management of adolescent low-risk classical Hodgkin lymphoma: which chemotherapy backbone gives the best chance of omitting radiotherapy safely","volume":"5","author":"Algiraigri","year":"2016","journal-title":"J\u00a0Adolesc Young Adult Oncol"},{"key":"10.1016\/j.jtumed.2020.08.004_bib4","unstructured":"McClain KL, Kamdar K. Overview of Hodgkin lymphoma in children and adolescents. In: UpToDate, Post, T.W. (Ed), UpToDate, Waltham, MA. (Accessed on Aug 01 2020)."},{"issue":"4","key":"10.1016\/j.jtumed.2020.08.004_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1182\/blood-2017-02-766121","article-title":"Encouraging activity for R-CHOP in advanced stage nodular lymphocyte-predominant Hodgkin lymphoma","volume":"130","author":"Fanale","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtumed.2020.08.004_bib6","first-page":"351431","article-title":"Lymphocyte-predominant Hodgkin's disease in children: a case study and review of the literature","volume":"2015","author":"Stier","year":"2015","journal-title":"Case Rep Oncol Med"},{"key":"10.1016\/j.jtumed.2020.08.004_bib7","unstructured":"LaCasce AS, Ng AK. Treatment of nodular lymphocyte-predominant Hodgkin lymphoma. In: UpToDate, Post, T.W. (Ed), UpToDate, Waltham, MA. (Accessed on Aug 02 2020)."},{"issue":"20","key":"10.1016\/j.jtumed.2020.08.004_bib8","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1200\/JCO.2015.65.3469","article-title":"Minimal treatment of low-risk, pediatric lymphocyte-predominant Hodgkin lymphoma: a report from the children's oncology Group","volume":"34","author":"Appel","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"10.1016\/j.jtumed.2020.08.004_bib9","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1056\/NEJMoa1915315","article-title":"Rituximab for high-risk, mature B-cell non-Hodgkin's lymphoma in children","volume":"382","author":"Minard-Colin","year":"2020","journal-title":"N\u00a0Engl J Med"}],"container-title":["Journal of Taibah University Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361220301268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1658361220301268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:27:36Z","timestamp":1761647256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1658361220301268"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S1658361220301268"],"URL":"https:\/\/doi.org\/10.1016\/j.jtumed.2020.08.004","relation":{},"ISSN":["1658-3612"],"issn-type":[{"type":"print","value":"1658-3612"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Minimising chemotherapy while optimising immune therapy for paediatric nodular lymphocyte-predominant Hodgkin's lymphoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Taibah University Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtumed.2020.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Production and hosting by Elsevier Ltd on behalf of Taibah University.","name":"copyright","label":"Copyright"}]}}